Come up with a name for your new list and we'll add to it:
Sividon Diagnostics was acquired by
Myriad Genetics on May 31, 2016.
Sividon Diagnostics develops breast cancer prognostic tests. Sividon's core EndoPredict product is a kit-based RNA expression test designed to assess the aggressiveness of breast cancer on a molecular…